6-Hour Virtual Seminar on FDA's Software Monsters

  • Check with publisher
  • Published date: January 17, 2020
    • Fremont, California, United States

The complexity and vulnerability of software is expanding exponentially, so fast that Congress removed some device software from FDA’s jurisdiction. The remaining software regulated by FDA presents a degree of a risk to health that creates a public health concern. Part of that risk involves the intentional activity that can conflict, intrude or destroy software. The problems are taking center stage in the "healthcare software" dialogue.

What issues can compromise or defeat the functional use of your software? Poor cybersecurity programs, lack of interoperability with third-party software, the wave of unmanageable apps and wireless home use technology. Original software design for an intended use is only the first step, the next design step is thinking about how someone can make your software worthless.

Result 0 votes
John Robinson
0 votes

Useful information

  • Avoid scams by acting locally or paying with PayPal
  • Never pay with Western Union, Moneygram or other anonymous payment services
  • Don't buy or sell outside of your country. Don't accept cashier cheques from outside your country
  • This site is never involved in any transaction, and does not handle payments, shipping, guarantee transactions, provide escrow services, or offer "buyer protection" or "seller certification"

Related listings

  • 6-Hour Virtual Seminar on Tougher Import Rules for FDA Imports in 2020

    6-Hour Virtual Seminar on Tougher Import Rules for FDA Imports in 2020

    Pharmacology - Drug Development Online Event (California) January 17, 2020 Check with publisher

    Importing FDA regulated products requires careful planning before you even start. Registration, product compliance, record and data submission must be exactly correct or your product will be detained. Likewise, the U.S. Customs and Border Protection ...

  • HIPAA, Consents, and 42 CFR Part 2

    HIPAA, Consents, and 42 CFR Part 2

    Pharmacology - Drug Development Fremont (California) December 4, 2019 Check with publisher

    Overview: For much of healthcare, HIPAA sets the standards for how to manage uses and disclosures of patient information, known as Protected Health Information (PHI). But when it comes to information related to the treatment of substance use disorder...

  • Physician Employment Agreements: Items to Consider

    Physician Employment Agreements: Items to Consider

    Pharmacology - Drug Development Fremont (California) October 22, 2019 Check with publisher

    Overview: We will review the various elements of the physician employment agreement, focusing on the pitfalls and the problems that can develop when the agreement does not clearly define the relationship, and/or when the parties do not fully understa...